NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX) concerning possible violations of federal securities laws. On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain […]

(NASDAQ:HNVR), Fourth Quarter Performance Highlights Net Income: Net income for the quarter ended December 31, 2024 totaled $3.9 million or $0.52 per diluted share (including Series A preferred shares). Record Non-interest Income: The Company reported record non-interest income of $4.2 million for the quarter ended December 31, 2024, an increase of $0.2 million or 5.89%

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Genuine Parts Company ("Genuine Parts Company") (NYSE:GPC) concerning possible violations of federal securities laws. On October 22, 2024, Genuine reported 3Q 2024 earnings that fell well below expectations and then lowered its

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Constellation Brands, Inc. ("Constellation Brands, Inc.") (NYSE:STZ) concerning possible violations of federal securities laws. On January 10, 2025, Constellation issued a press release announcing the company’s third quarter fiscal year 2025 results,

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Grocery Outlet Holding Corp. ("Grocery Outlet Holding Corp.") (NASDAQ:GO) concerning possible violations of federal securities laws. On May 7, 2024, Grocery Outlet reported 1Q 2024 earnings that fell well below expectations and

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation ("Universal Display Corporation") (NASDAQ:OLED) concerning possible violations of federal securities laws. On August 1, 2024, Universal reported solid 2Q 2024 results and raised the bottom-end of its full year

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=125714&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=125711&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K. Therein, the Company announced that it would

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=125715&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call